Changes in body mass index following HAART initiation among HIVinfected women in the women’s interagency HIV study

Journal of AIDS and Clinical Research

Volumn 5, Issue 7, 2014, Pages 2-8

  Sharma, Anjali ^a   Bynum, Shalanda A ^b   Schneider, Michael F ^c   Cox, Christopher ^c   Tien, Phyllis C ^d   Hershow, Ronald C ^e   Gustafson, Deborah ^f   Plankey, Michael W ^g  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f SUNY Downstate Medical Center   (United States)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Body mass index; HAART; HIV; Obesity; Women; Women s interagency HIV study

Indexed keywords

EID: 84907276405     PISSN: None     EISSN: 21556113     Source Type: Journal    
DOI: 10.4172/2155-6113.1000323     Document Type: Article

References (34)

1. Ekali LG, Johnstone LK, Echouffo-Tcheugui JB, Kouanfack C, Dehayem MY, et al. (2013) Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment. Diabetes Metab 39: 71-77.
2. Buchacz K, Baker RK, Palella FJ Jr, Shaw L, Patel P, et al. (2013) Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther 18: 65-75.
3. Boodram B, Plankey MW, Cox C, Tien PC, Cohen MH, et al. (2009) Prevalence and correlates of elevated body mass index among HIV-positive and HIVnegative women in the Women's Interagency HIV Study. AIDS Patient Care STDS 23: 1009-1016.
4. Amorosa V, Synnestvedt M, Gross R, Friedman H, MacGregor RR, et al. (2005) A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr 39: 557-561.
5. Tedaldi EM, Brooks JT, Weidle PJ, Richardson JT, Baker RK, et al. (2006) Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr 43: 35-41.
6. Centers for Disease Control and Prevention (2011) Behavioral Risk Factor Surveillance System Survey. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
7. Ferrando SJ, Rabkin JG, Lin SH, McElhiney M (2005) Increase in body cell mass and decrease in wasting are associated with increasing potency of antiretroviral therapy for HIV infection. AIDS Patient Care STDS 19: 216-223.
8. Karmon SL, Moore RD, Dobs AS, Keruly J, Barnett S, et al. (2005) Body shape and composition in HIV-infected women: an urban cohort. HIV Med 6: 245-252.
9. Silva M, Skolnik PR, Gorbach SL, Spiegelman D, Wilson IB, et al. (1998) The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 12: 1645-1651.
10. Wand H, Ramjee G (2013) High prevalence of obesity among women who enrolled in HIV prevention trials in KwaZulu-Natal, South Africa: healthy diet and life style messages should be integrated into HIV prevention programs. BMC Public Health 13: 159.
11. Crum-Cianflone N, Tejidor R, Medina S, Barahona I, Ganesan A (2008) Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS 22: 925-930.
12. Crum-Cianflone N, Roediger MP, Eberly L, Headd M, Marconi V, et al. (2010) Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One 5: e10106.
13. Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, et al. (2004) Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA 292: 191-201.
14. Mallon PW, Miller J, Cooper DA, Carr A (2003) Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS 17: 971-979.
15. Shikuma CM, Zackin R, Sattler F, Mildvan D, Nyangweso P, et al. (2004) Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis 39: 1223-1230.
16. Tate T, Willig AL, Willig JH, Raper JL, Moneyham L, et al. (2012) HIV infection and obesity: where did all the wasting go? Antivir Ther 17: 1281-1289.
17. Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, et al. (2005) The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 12: 1013-1019.
18. National Institutes of Health (1998) Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. Obesity Research 6: 51S-209S.
19. Bozzette SA, Hays RD, Berry SH, Kanouse DE, Wu AW (1995) Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 8: 253-265.
20. Liu C, Weber K, Robison E, Hu Z, Jacobson LP, et al. (2006) Assessing the effect of HAART on change in quality of life among HIV-infected women. AIDS Res Ther 3: 6.
21. Radloff LS, Rae DS (1979) Susceptibility and precipitating factors in depression: sex differences and similarities. J Abnorm Psychol 88: 174-181.
22. Koenker R, Hallock K (2001) Quantile Regression. J Econ Perspect 15: 143-156.
23. Cox C, Chu H, Schneider MF, Muñoz A (2007) Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Stat Med 26: 4352-4374.
24. Justman JE, Hoover DR, Shi Q, Tan T, Anastos K, et al. (2008) Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women. J Acquir Immune Defic Syndr 47: 312-319.
25. Palenicek JP, Graham NM, He YD, Hoover DA, Oishi JS, et al. (1995) Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol 10: 366-373.
26. Jones CY, Hogan JW, Snyder B, Klein RS, Rompalo A, et al. (2003) Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis 37: S69-80.
27. Shor-Posner G, Campa A, Zhang G, Persaud N, Miguez-Burbano MJ, et al. (2000) When obesity is desirable: a longitudinal study of the Miami HIV-1- infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr 23: 81-88.
28. Lakey W, Yang LY, Yancy W, Chow SC, Hicks C (2013) Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIVinfected persons. AIDS Res Hum Retroviruses 29: 435-440.
29. Hodgson LM, Ghattas H, Pritchitt H, Schwenk A, Payne L, et al. (2001) Wasting and obesity in HIV outpatients. AIDS 15: 2341-2342.
30. Flegal KM, Kit BK, Orpana H, Graubard BI (2013) Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309: 71-82.
31. Shuter J, Chang CJ, Klein RS (2001) Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr 26: 291-297.
32. Bray GA (1985) Complications of obesity. Ann Intern Med 103: 1052-1062.
33. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB (2002) Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162: 1867-1872.
34. NHLBI Obesity Education Initiative (2000) The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults.